[Federal Register Volume 84, Number 90 (Thursday, May 9, 2019)]
[Notices]
[Pages 20438-20439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09485]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2016-0190]


Program-Specific Guidance About Commercial Radiopharmacy Licenses

AGENCY: Nuclear Regulatory Commission.

ACTION: NUREG; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has issued 
Revision 2 to NUREG-1556, Volume 13, ``Consolidated Guidance About 
Materials Licenses: Program-Specific Guidance About Commercial 
Radiopharmacy Licenses.'' Volume 13 of NUREG-1556 has been revised to 
include information on updated regulatory requirements, safety culture, 
security of radioactive materials, protection of sensitive information, 
and changes in regulatory policies and practices consistent with 
current regulations. This volume is intended for use by applicants, 
licensees, and the NRC staff.

DATES: NUREG-1556, Volume 13, Revision 2, was published in March 2019.

ADDRESSES: Please refer to Docket ID NRC 2016-0190, when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2016-0190. Address 
questions about NRC Docket IDs in regulations.gov to Jennifer Borges; 
telephone: 301-287-9127; email: [email protected]. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. 
NUREG-1556, Volumes 13, Revision 2, is located at ADAMS Accession 
Number ML18180A187. This document is also available on the NRC's public 
website at http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/ under ``Consolidated Guidance About Materials Licenses (NUREG-
1556).''
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Anthony McMurtray, Office of Nuclear 
Material Safety and Safeguards; U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2746; email: 
[email protected].

SUPPLEMENTARY INFORMATION: 

I. Discussion

    The NRC issued a revision to NUREG-1556, Volumes 13, to provide 
guidance to existing materials licensees covered under commercial 
radiopharmacy licenses and to applicants preparing an application for a 
commercial radiopharmacy license. This NUREG volume also provides the 
NRC staff with criteria for evaluating commercial radiopharmacy license 
applications. The purpose of this notice is to notify the public that 
the NUREG-1556 volume listed in this document was issued as a final 
report.

II. Additional Information

    The NRC published a notice of the availability of the draft report 
for comment version of NUREG-1556, Volume 13, Revision 2 in the Federal 
Register on January 24, 2017 (82 FR 8227), with a public comment period 
of 59 days. The public comment period closed on March 24, 2017. Public 
comments and the NRC staff responses

[[Page 20439]]

to the public comments for NUREG-1556, Volume 13, Revision 2 are 
available in ADAMS under Accession No. ML18305B303.

III. Congressional Review Act

    This NUREG volume is a rule as defined in the Congressional Review 
Act (5 U.S.C. 801-808). However, the Office of Management and Budget 
has not found this NUREG revision to be a major rule as defined in the 
Congressional Review Act.

    Dated at Rockville, Maryland, this 2nd day of May 2019.

    For the Nuclear Regulatory Commission.
Andrea L. Kock,
Director, Division of Materials Safety, Security, State and Tribal 
Programs, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2019-09485 Filed 5-8-19; 8:45 am]
BILLING CODE 7590-01-P